You are here

Article Text

Article menu
Download PDFPDF
Editorial
Treatment of Anderson–Fabry disease

https://doi.org/10.1136/hrt.2006.113886

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: AL is a member of the executive committee of the Fabry Outcome Survey, supported by Shire Human Genetic Therapies (previously Transkaryotic Therapies Inc.). As an employee of Charles University, Prague, CZ, AL does not receive compensation from Shire Human Genetic Therapies. The company has paid his travel expenses to meetings related to the research collaboration.

    Linked Articles